IP Library Assignment 030983/0675
Patent Assignment
Reel/Frame 030983/0675

Confirmatory Assignment

Recorded: 2013-08-06 Pages: 5
Assignor
LANZA, ROBERT
Executed: 2013-08-06
Assignee
ADVANCED CELL TECHNOLOGY, INC.
33 LOCKE DRIVE, MARLBOROUGH, MASSACHUSETTS, 01752
Covered Properties (3)
Improved Modalities for the Treatment of Degenerative Diseases of the Retina
Methods for Producing Enriched Populations of Human Retinal Pigment Epithelium Cells for Treatment of Retinal Degeneration
Patent: 7,794,704 →
Application: 11/041,382 →
Publication: US 2006/0031951
Modalities for the treatment of degenerative diseases of the retina
Application: 60/538,964 →
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Agreement Jan 25, 2013
From: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
To: CAMOFI MASTER LDC; CAMHZN MASTER LDC
Reel/Frame 029698/0001 →
Release of Security Interest Nov 24, 2014
From: CAMOFI MASTER LDC; CAMHZN MASTER LDC
To: ADVANCED CELL TECHNOLOGY, INC.; MYTOGEN, INC.
Reel/Frame 034421/0863 →
Change of Name Feb 13, 2015
From: ADVANCED CELL TECHNOLOGY, INC.
To: OCATA THERAPEUTICS, INC.
Reel/Frame 034999/0826 →
Change of Name Jul 27, 2016
From: OCATA THERAPEUTICS, INC.
To: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
Reel/Frame 039493/0166 →
Confirmatory Assignment Apr 5, 2024
From: ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE
To: PRESIDENT AND FELLOWS OF HARVARD COLLEGE
Reel/Frame 067024/0057 →